FindMyKOL
Clinical trialNCT01515761UnknownInterventional

POsition of Leads in Advanced heaRt Failure: the POLAR Study

NCT01515761 is an interventional trial sponsored by Sergio Thal, M.D.. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies Cardiac Resynchronization Therapy and Heart Failure. The registry lists an enrollment of 60 participants at 2 sites in 1 country. The registry lists a start date of 30 Sept 2010 and a primary completion date of 31 Mar 2013.

SponsorSergio Thal, M.D.Enrollment60Cardiac Resynchronization TherapyHeart Failure
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01515761
FieldValue
Registry IDNCT01515761
StatusUnknown
Study typeInterventional trial
Lead sponsorSergio Thal, M.D.
Enrollment60
Registered sites2
Countries1
ConditionsCardiac Resynchronization Therapy and Heart Failure
Start30 Sept 2010
Primary completion31 Mar 2013
Last update posted24 Jan 2012

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective is to determine if lead positioning in the lateral wall of the left ventricle in patients meeting criteria for cardiac resynchronization therapy plays a role in determining myocardial function and affects the severity of mitral regurgitation.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Arizona, United States1 site, 1 recruiting
  • Southern Arizona Va Health Care System

    Tucson

    Elizabeth Juneman, M.D.Hoang Thai, M.D.Sergio Thal, M.D.
    Recruiting
Kentucky, United States1 site, 1 recruiting
  • Lexington Va Medical Center

    Lexington

    Samy Elayi, M.D.
    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentucky: 1 site, 1 recruitingKY1West VirginiaWVVirginiaVAMarylandMDDelawareDEArizona: 1 site, 1 recruitingAZ1UtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01515761

Each answer restates registry values shown on this page.

What is NCT01515761?

NCT01515761 is an interventional trial sponsored by Sergio Thal, M.D.. It studies Cardiac Resynchronization Therapy and Heart Failure.

Who leads NCT01515761?

The registry names Sergio Thal, M.D. (principal investigator, Southern Arizona VA Health Care System) as the overall official.

Where does NCT01515761 run?

The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.

When is NCT01515761 expected to complete?

The registry lists a primary completion date of 31 Mar 2013. The sponsor last updated the record on 24 Jan 2012.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.